TLSI Dividend: TriSalus Life Sciences Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

TLSI Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	35	29	18	0	0	0
Revenue Growth (YoY)	13%	61%	--	--	--	--
Cost of Revenue	5	4	2	--	--	--
Gross Profit	30	25	15	--	--	--
Selling, General & Admin	47	43	40	2	3	0
Research & Development	14	17	29	--	--	--
Operating Expenses	61	61	70	2	3	0
Other Non Operating Income (Expenses)	4	8	0	5	7	0
Pretax Income	-31	-30	-59	6	4	0
Income Tax Expense	0	0	0	0	--	--
Net Income	-34	-33	-63	5	4	0
Net Income Growth	-40%	-48%	-1,360%	25%	--	--
Shares Outstanding (Diluted)	32.89	25.33	9.39	29.61	31.25	30.56
Shares Change (YoY)	37%	170%	-68%	-5%	2%	--
EPS (Diluted)	-1.03	-1.31	-6.76	0.19	0.15	-0.02
EPS Growth	-56.99%	-81%	-3,663%	27%	-850%	--
Free Cash Flow	-29	-41	-51	-2	-1	0
Free Cash Flow Per Share	-0.88	-1.61	-5.42	-0.06	-0.03	0
Gross Margin	85.71%	86.2%	83.33%	--	--	--
Operating Margin	-85.71%	-124.13%	-300%	0%	0%	0%
Profit Margin	-97.14%	-113.79%	-350%	0%	0%	0%
Free Cash Flow Margin	-82.85%	-141.37%	-283.33%	0%	0%	0%
EBITDA	-30	-36	-54	--	--	--
EBITDA Margin	-85.71%	-124.13%	-300%	--	--	--
D&A For EBITDA	0	0	0	--	--	--
EBIT	-30	-36	-54	-2	-3	0
EBIT Margin	-85.71%	-124.13%	-300%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	--	--